The global guidewires market, valued at USD 874.85 million in 2024, is expected to grow at a CAGR of 5.30% from 2025 to 2034, reaching USD 1.47 billion by 2034. This growth is driven by the rising prevalence of cardiovascular diseases, peripheral artery disease, and urological disorders. Guidewires play a crucial role in ensuring precision during interventional procedures, particularly in cardiovascular and peripheral vascular applications. Advancements in healthcare infrastructure and increasing awareness about minimally invasive procedures are also contributing to the market’s expansion.